Generated by AI
The iShares Global Healthcare ETF is an exchange-traded fund designed to provide investors with broad exposure to the global healthcare sector. This ETF seeks to track the investment results of an index composed of global companies in the healthcare sector, offering a diversified investment in organizations involved in manufacturing pharmaceuticals, medical devices, biotechnology products, and providers of health services. The healthcare industry is known for its resilience and potential for growth, as it addresses critical global needs such as increasing life expectancy, aging populations, and the continuous demand for medical advancements. The ETF includes holdings across different regions, allowing investors to gain exposure to international markets and benefit from innovations and developments across the healthcare industry globally. iShares Global Healthcare ETF plays a significant role in the market by enabling portfolio diversification and providing a relatively consistent historical performance compared to other sectors, considering healthcare's essential nature. It is especially relevant for investors looking to capitalize on long-term trends in health and wellness and those seeking to manage risk through diversified global investments in a single fund.
The latest articles about IXJ.
Investing.com -- Healthcare often acts as a shelter because people keep buying medicine and care in any economy. The screener (snapshot data, which may lag live prices) points to a few broad, low-cost US funds. Nasdaq-100 funds like Invesco QQQ Trust (QQQ) fell about 9% over 3 months. Healthcare funds gained roughly 10-12% over the same period.
PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.
IXJ offers diversified global exposure at lower cost, while FBT concentrates on biotech with higher volatility and stronger recent returns.
U.S. healthcare stocks delivered 28.8% gains over one year versus 22.5% for international peers. Both funds carry nearly identical expense ratios and low volatility profiles.
FHLC delivered 24% returns over one year with a 0.08% expense ratio, while IXJ offers global diversification but trails on performance and costs more to own.
Summary of Jan 24's posts. Generated by AI.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about IXJ also mention these. Each card shows that asset’s own numbers for the past 24 hours.